Refining Risk for Alzheimer's Disease Among Heterozygous APOE ε4 Carriers

被引：4

作者：

Patel, Smita ^{[1
]}

Wei, Jun ^{[2
]}

Shi, Zhuqing ^{[2
]}

Rifkin, Andrew S. ^{[2
]}

Zheng, S. Lilly ^{[2
]}

Gelfman, Elizabeth ^{[3
]}

Duggan, David ^{[4
]}

Helfand, Brian T. ^{[2
,5
]}

Hulick, Peter J. ^{[6
]}

Xu, Jianfeng ^{[2
,5
]}

机构：

[1] NorthShore Univ HlthSyst, Dept Neurol, Evanston, IL USA

[2] NorthShore Univ HlthSyst, Program Personalized Canc Care, Evanston, IL USA

[3] Northwestern Feinberg Sch Med, Chicago, IL USA

[4] City Hope Natl Med Ctr, Translat Genom Res Inst, Phoenix, AZ USA

[5] Univ Chicago, Pritzker Sch Med, Chicago, IL USA

[6] NorthShore Univ HlthSyst, Neaman Ctr Personalized Med, Evanston, IL USA

来源：

JOURNAL OF ALZHEIMERS DISEASE | 2023年 / 94卷 / 02期

关键词：

Alzheimer's disease; APOE; genetic counseling; polygenic risk score; UK Biobank; APOLIPOPROTEIN-E; DISCLOSURE; GENOTYPE;

D O I：

10.3233/JAD-230156

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

In a large population-based cohort, we show not all heterozygous APOE epsilon 4 carriers are at increased risk for Alzheimer's disease (AD); a significantly higher AD proportion was only found for epsilon 3/epsilon 4, not epsilon 2/epsilon 4. Among epsilon 3/epsilon 4 carriers (24% in the cohort), the AD proportion differed considerably by polygenic risk score (PRS). In particular, the AD proportion was lower than the entire cohort for subjects in the bottom 20-percentile PRS and was higher than that of homozygous epsilon 4 carriers for subjects at the top 5th-percentile PRS. Family history was no longer a significant predictor of AD risk after adjusting APOE and PRS.

引用

页码：483 / 489

页数：7

共 50 条

[11] A Systems View of the Differences between APOE ε4 Carriers and Non-carriers in Alzheimer's Disease
Jiang, Shan
Tang, Ling
Zhao, Na
Yang, Wanling
Qiu, Yu
Chen, Hong-Zhuan
FRONTIERS IN AGING NEUROSCIENCE, 2016, 8
[12] GAB2 alleles modify Alzheimer's risk in APOE ε4 carriers
Reiman, Eric M.
Webster, Jennifer A.
Myers, Amanda J.
Hardy, John
Dunckley, Travis
Zismann, Victoria L.
Joshipura, Keta D.
Pearson, John V.
Hu-Lince, Diane
Huentelman, Matthew J.
Craig, David W.
Coon, Keith D.
Liang, Winnie S.
Herbert, RiLee H.
Beach, Thomas
Rohrer, Kristen C.
Zhao, Alice S.
Leung, Doris
Bryden, Leslie
Marlowe, Lauren
Kaleem, Mona
Mastroeni, Diego
Grover, Andrew
Heward, Christopher B.
Ravid, Rivka
Rogers, Joseph
Hutton, Michael L.
Melquist, Stacey
Petersen, Ron C.
Alexander, Gene E.
Caselli, Richard J.
Kukull, Walter
Papassotiropoulos, Andreas
Stephan, Dietrich A.
NEURON, 2007, 54 (05) : 713 - 720
[13] Bioenergetic and inflammatory systemic phenotypes in Alzheimer's disease APOE ε4-carriers
Wilkins, Heather M.
Wang, Xiaowan
Menta, Blaise W.
Koppel, Scott J.
Bothwell, Rebecca
Becker, Annette M.
Anderson, Heidi
Schwartz, Erin
Pei, Dong
Yellapu, Nanda K.
Chalise, Prabhakar
Gouvion, Cynthia M.
Haeri, Mohammad
Burns, Jeffrey M.
Swerdlow, Russell H.
AGING CELL, 2021, 20 (05)
[14] APOEε4 and risk of Alzheimer's disease - time to move forward
Lefterov, Iliya
Fitz, Nicholas F.
Lu, Yi
Koldamova, Radosveta
FRONTIERS IN NEUROSCIENCE, 2023, 17
[15] Genetic mutations of APOEε4 carriers in cardiovascular patients lead to the development of insulin resistance and risk of Alzheimer's disease
Jabeen, Komal
Rehman, Kanwal
Akash, Muhammad Sajid Hamid
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2022, 36 (02)
[16] The MAPT H1 Haplotype Is a Risk Factor for Alzheimer's Disease in APOE ε4 Non-carriers
Sanchez-Juan, Pascual
Moreno, Sonia
de Rojaso, Itziar
Hernandez, Isabel
Valero, Sergi
Alegret, Montse
Montrreal, Laura
Garcia Gonzalez, Pablo
Lage, Carmen
Lopez-Garcia, Sara
Rodriiguez-Rodriguez, Eloy
Orellana, Adelina
Tarraga, Lluis
Boada, Merce
Ruiz, Agustin
Abdelnour, C.
Aguilera, N.
Alarcon, E.
Alegret, M.
Boada, M.
Buendia, M.
Canabate, P.
de Rojas, I
Diego, S.
Espinosa, A.
Gailhajenet, A.
Garcia Gonzalez, P.
Gil, S.
Guitart, M.
Hernandez, I
Ibarria, M.
Lafuente, A.
Martin, E.
Mauleon, A.
Monte-Rubio, G.
Montrreal, L.
Moreno-Grau, S.
Moreno, M.
Orellana, A.
Ortega, G.
Pancho, A.
Peleja, E.
Perez-Cordon, A.
Preckler, S.
Rodriguez-Gomez, O.
Rosende-Roca, M.
Ruiz, A.
Ruiz, S.
Sanabria, A.
Santos-Santos, M. A.
FRONTIERS IN AGING NEUROSCIENCE, 2019, 11
[17] Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease
Konishi, Kyoko
Joober, Ridha
Poirier, Judes
MacDonald, Kathleen
Chakravarty, Mallar
Patel, Raihaan
Breitner, John
Bohbot, Veronique D.
JOURNAL OF ALZHEIMERS DISEASE, 2018, 61 (04) : 1493 - 1507
[18] Novel Alzheimer’s disease risk variants identified based on whole-genome sequencing of APOE ε4 carriers
Jong-Ho Park
Inho Park
Emilia Moonkyung Youm
Sejoon Lee
June-Hee Park
Jongan Lee
Dong Young Lee
Min Soo Byun
Jun Ho Lee
Dahyun Yi
Sun Ju Chung
Kye Won Park
Nari Choi
Seong Yoon Kim
Woon Yoon
Hoyoung An
Ki woong Kim
Seong Hye Choi
Jee Hyang Jeong
Eun-Joo Kim
Hyojin Kang
Junehawk Lee
Younghoon Kim
Eunjung Alice Lee
Sang Won Seo
Duk L. Na
Jong-Won Kim
Translational Psychiatry, 11
[19] Novel Alzheimer's disease risk variants identified based on whole-genome sequencing of APOE ε4 carriers
Park, Jong-Ho
Park, Inho
Youm, Emilia Moonkyung
Lee, Sejoon
Park, June-Hee
Lee, Jongan
Lee, Dong Young
Byun, Min Soo
Lee, Jun Ho
Yi, Dahyun
Chung, Sun Ju
Park, Kye Won
Choi, Nari
Kim, Seong Yoon
Yoon, Woon
An, Hoyoung
Kim, Ki Woong
Choi, Seong Hye
Jeong, Jee Hyang
Kim, Eun-Joo
Kang, Hyojin
Lee, Junehawk
Kim, Younghoon
Lee, Eunjung Alice
Seo, Sang Won
Na, Duk L.
Kim, Jong-Won
TRANSLATIONAL PSYCHIATRY, 2021, 11 (01)
[20] Vascular Dysfunction Is Central to Alzheimer's Disease Pathogenesis in APOE e4 Carriers
McCorkindale, Andrew N.
Mundell, Hamish D.
Guennewig, Boris
Sutherland, Greg T.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)

← 1 2 3 4 5 →